Name: OKUR Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: OKUR, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does OKUR have?

Accepted Answer

OnKure Therapeutics, Inc. (OKUR) has 8 SEC Form 4 filings (8 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jun 24, 2026.

Question 2

When was the most recent SEC Form 4 filing for OKUR?

Accepted Answer

The most recent Form 4 filing for OKUR on Tracefour is dated Jun 24, 2026.

Question 3

Who is the most active insider at OKUR?

Accepted Answer

The most active SEC Form 4 filer at OKUR in the rolling window is President and CEO Saccomano Nicholas A, with 3 filings.

Question 4

What is the net insider flow at OKUR over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at OKUR have net sold $3K based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at OKUR in the current window?

Accepted Answer

Inside the rolling window, insiders at OKUR bought $0 and sold $4K based on SEC Form 4 filings.

Question 6

Can I get alerts for OKUR insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at OnKure Therapeutics, Inc. (OKUR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
Saccomano Nicholas AFirst in 3 months	President and CEO	Sale	86	$378	Jun 24	SEC ↗
Leverone Jason A.First in 3 months	Chief Financial Officer	Sale	303	$1K	Jun 24	SEC ↗
Saccomano Nicholas AFirst in 3 months	President and CEO	Sale	86	$357	Mar 24	SEC ↗
Leverone Jason A.First in 3 months	Chief Financial Officer	Sale	301	$1K	Mar 24	SEC ↗
Saccomano Nicholas AFirst filing	President and CEO	Sale	87	$258	Dec 23	SEC ↗
Leverone Jason A.First filing	Chief Financial Officer	Sale	302	$896	Dec 23	SEC ↗

OKUR

Related companies